Determination of Alzheimer's Disease Stages by Artificial Learning Algorithms

dc.contributor.authorBulut, Nurgül
dc.contributor.authorÇakar, Tuna E.
dc.contributor.authorArslan, İlker
dc.contributor.authorAkıncı, Zeynep Karaoğlu
dc.contributor.authorOner, Kevser Setenay
dc.date.accessioned2025-11-16T19:25:05Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractIntroduction: This study aims to determine the stages of Alzheimer's disease (AD) using different machine learning algorithms, and compares the performance of these models. Methods: Demographic, genetic, and neurocognitive inventory data from the National Alzheimer's Coordinating Center (NACC) database as well as brain volume/thickness data from magnetic resonance imaging (MRI) scans were used. Deep Neural Networks, Ordinal Logistic Regression, Random Forest, Gaussian Naive Bayes, XGBoost, and LightGBM models were used to identify four different ordinal stages of AD. Results: Although the performance measures of the developed models were similar, the highest classification rate of AD stages was achieved by the Random Forest model (accuracy: 0.86; F1 score: 0.86; AUC: 0.95). The outputs of the model with the best performance were explained by the SHapley Addictive exPlanations (SHAP) method. Conclusions: This indicates that non-invasive markers and machine learning models can be used effectively in early diagnosis and decision support systems to predict stages of AD. © 2025 Elsevier B.V., All rights reserved.
dc.description.sponsorshipNational Institute on Aging, NIA; National Institutes of Health, NIH, (P30 AG066514, P30 AG072977, P30 AG072973, P30 AG066518, P30 AG086401, P30 AG072946, P30 AG072947, P30 AG072979, P30 AG072958, P30 AG066462, P30 AG062422, P30 AG066444, P30 AG066506, P30 AG072931, P30 AG066468, P30 AG066530, P30 AG072972, P30 AG086404, P20 AG068082, P30 AG072976, P30 AG066509, P30 AG066519, P30 AG072959, P30 AG062677, P30 AG066546, P30 AG066511, P30 AG062429, P30 AG066515, P30 AG062421, P30 AG066512, P30 AG079280, P30 AG066507, P30 AG072975, P30 AG062715, P30 AG066508, P30 AG072978, U24 AG072122); National Institutes of Health, NIH
dc.identifier.doi10.6000/1929-6029.2025.14.50
dc.identifier.endpage542
dc.identifier.issn1929-6029
dc.identifier.scopus2-s2.0-105016678414
dc.identifier.scopusqualityQ3
dc.identifier.startpage532
dc.identifier.urihttps://doi.org/10.6000/1929-6029.2025.14.50
dc.identifier.urihttps://hdl.handle.net/20.500.14730/14607
dc.identifier.volume14
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherLifescience Global
dc.relation.ispartofInternational Journal of Statistics in Medical Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20251116
dc.subjectAlzheimer's Disease
dc.subjectArtificial Intelligence
dc.subjectArtificial Learning Algorithm
dc.subjectExplainable Artificial Intelligence
dc.subjectMachine Learning
dc.subjectNational Alzheimer's Coordinating Center
dc.subjectSHapley Addictive exPlanations
dc.titleDetermination of Alzheimer's Disease Stages by Artificial Learning Algorithms
dc.typeArticle

Dosyalar